NGM·Healthcare·$1.1B·#22 / 520 in Healthcare
IRMD iRadimed Corporation
77SOLID
CATEGORY BREAKDOWN
GROWTH23
QUALITY94
STABILITY100
VALUATION36
GOVERNANCE99
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+14.4%
23
> 50% strong
Gross Margin
Revenue retained after direct costs
76.7%
100
> 50% strong
Cash Runway
Months of cash at current burn rate
999 months
100
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
0.0%
100
< 25% strong
Price / Sales
Market cap relative to trailing revenue
12.7x
36
< 3x strong
Rule of 40
Growth rate plus operating margin
46
86
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
36.6%
100
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+0.5%
97
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE IRMD WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when IRMD's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.